A study of malpractice lawsuits related to found "no evidence of successful malpractice litigation," leading the authors to conclude that active surveillance "represents a sound management option in appropriate low-risk cancers." (Annals of Surgery)
Some veterans exposed to Agent Orange and other toxins have been from the Veterans Administration for cancers and other illness linked to the toxins. (KFF Health News)
The FDA has issued three draft guidance documents that make recommendations to . (Regulatory Focus)
Trastuzumab deruxtecan (Enhertu) significantly improved progression-free survival in a randomized study of after at least one line of endocrine therapy, AstraZeneca announced.
The FDA approved the (Herceptin), trastuzumab-strf (Hercessi), for HER2-positive breast and stomach cancers, Accord BioPharma announced.
Meanwhile, Sandoz resolved a patent dispute over its (Prolia, Xgeva). (Reuters)
Merck announced that the phase III KEYNOTE-811 trial showed significant improvement in progression-free and overall survival in treated with pembrolizumab (Keytruda), trastuzumab, and platinum-based chemotherapy.
In a series of laboratory studies, adding a to cancer therapy significantly improved anti-cancer activity in a model of prostate cancer. (University of Notre Dame)
is two to three times higher among Native Hawaiian and other Pacific Islander Americans, according to a report from the American Cancer Society.
An investigational blood test showed potential for identifying patients with an , years before actual diagnosis. (Mass General Brigham, Beth Israel Deaconess Medical Center)
![author['full_name']](https://clf1.medpagetoday.com/media/images/author/charlesBankhead_188.jpg)